Non-typhoid salmonellosis is an infectious disease caused by Salmonella species other than Salmonella typhi. Although the usual clinical course of non-typhoid salmonellosis is a benign self-limiting gastroenteritis, these bacteria are especially problematic in immunocompromised individuals, including patients with malignancies, human immunodeficiency virus, or diabetes, and those receiving corticosteroids or other immunotherapy agents. In addition to enteric symptoms, Salmonella species give rise to extra-intestinal complications, including self-limiting arthritis, which appears 1 to 3 weeks after the onset of infection and lasts from a few weeks to several months. In some patients, however, this arthritis spears to be chronic in nature. We describe herein a living-donor liver transplant recipient who experienced non-typhoid Salmonella-triggered arthritis in the left hip. The patient recovered uneventfully after 6-month-long antibiotics treatment. 
INTRODUCTION
Salmonellae are enteric pathogens and a leading cause of bacterial food borne illness. Non-typhoid salmonellosis is an infectious disease caused by Salmonella species other than Salmonella typhi. In most patients, the clinical course of non-typhoid salmonellosis consists of a benign self-limiting gastroenteritis. However, these bacteria are especially problematic in immunocompromised individuals, including patients with malignancy, human immunodeficiency virus, or diabetes, and those treated with corticosteroids or other immunotherapy agents. In addition to enteric symptoms, Salmonella species give rise extra-intestinal complications, which are associated with increased mortality rates and graft failure in transplant recipients.
Salmonella-triggered arthritis may appear 1 to 3 weeks after the onset of infection. This arthritis is frequently asymmetric and migratory and usually involves the large joints. In most patients, this arthritis is self-limiting and lasts a few weeks to several months, but in some patients the disease appears to be chronic in nature. We describe here a patient who experienced non-typhoid Salmonellatriggered arthritis in the left hip after undergoing dual living-donor liver transplantation.
CASE
A 47-year-old man underwent a dual living-donor liver transplantation, consisting of the right lobe from his wife and the left lobe from his brother, due to hepatitis B, liver cirrhosis and hepatocellular carcinoma in February 2010.
Postoperatively, he was treated with tacrolimus (initially 0.025 mg/kg/day intravenous injection switched into 3.5 mg per oral administration (per os) twice a day) and methyl prednisolone (initially 50 mg intravenous injection, every 6 hours switched into 12 mg per os twice a day). The serum level of tacrolimus was adjusted to 14.6 ng/ml (normal range, 5-20 ng/ml) and his graft function was excellent. He discharged in stable condition of day 24 of the onset of the gastrointestinal symptoms. 4 The pathogenesis of reactive arthritis remains obscure, although it is strongly associated with the presence of the major histocompatibility antigen HLA-B27, which may predict a more prolonged and severe disease. 5, 6 The incidence of arthritis following Salmonella infections has been reported to range 2-15% and incidence of 3.4 % has been reported in renal transplant recipients. 1 The median times from onset of gastrointestinal symptoms to the development of arthritis have been found to range from 0 to 90 days, with the usual onset being within 7 to 14 days. [4] [5] [6] [7] [8] [9] The sequence of events that lead to bone and joint in- However, intra-articular injection of steroids is still considered problematic due to the possibility of secondary infections. 9, 10 Clinical responses are based on the resolution of fever, pain and joint effusion.
11
The prognosis of patients with arthritis after Salmonella infections has not been well defined. Although most patients show resolution of arthritis within 4 months of onset, chronic symptoms can persist for up to 5 years. 4 Moreover, relapse can occur, even with appropriate therapy. In an Israeli series, 2.2% of patients experienced a bacteriologically proven relapse. 12 The relapse rate is sig- Patients with Salmonella bacteremia susceptible to ciprofloxacin. 13 We herein report a dual living-donor liver transplant recipient who had quinolone-resistant, non-typhoidal samonella septic arthritis and that at least 6 months of treatment with cefixime and trimethoprim-sulfamethoxazole would lead to an acceptable outcome, as well as prevention of insidious progress of arthritis and permanent joint damage.
